Clinical Trial Update: A Study to Compare the Pharmacokinetic Characteristics of CJ-12420 [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the pharmacokinetic characteristics of CJ-12420 for erosive esophagitis; the study sponsored by HK inno.N Corporation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis

Drugs mentioned

• CJ-12420

Snippet

Sponsor: HK inno.N Corporation | Conditions: Erosive Esophagitis | Phase 1 | Status: COMPLETED